Hodgkin's Disease News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients - News-Medical.net



News-Medical.net
 
CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients 
News-Medical.net
In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah? (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin's lymphoma (NHL) patients. Results from a ...
CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive Medscape

all 18 news articles » 


Antibody-Drug Conjugate Ups PFS in Untreated Hodgkin's - MedPage Today



Antibody-Drug Conjugate Ups PFS in Untreated Hodgkin's 
MedPage Today
ATLANTA -- Upfront treatment with the antibody-drug conjugate (ADC) brentuximab vedotin (Adcetris) led to significantly better progression-free survival (PFS) for patients with newly diagnosed advanced Hodgkin lymphoma, investigators reported here ...

and more » 


BeiGene (BGNE) Highlights Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) in Non-Hodgkin's ... - StreetInsider.com



BeiGene (BGNE) Highlights Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) in Non-Hodgkin's ... 
StreetInsider.com
BeiGene, Ltd. (NASDAQ: BGNE) today presented preliminary clinical data from an ongoing Phase 1b trial of its investigational Bruton's Tyrosine Kinase (BTK) inhibitor zanubrutinib (BGB-3111) in patients with non-Hodgkin's lymphoma (NHL) in an oral ...

and more » 


From Cancer to Campus: The Eagles Scholarship Helping Dragons Soar - Drexel Now



From Cancer to Campus: The Eagles Scholarship Helping Dragons Soar 
Drexel Now
Stephen DiPietro was cleaning out his garage last month when he stopped, arrested by an old photo he wishes he could forget. In it, his son, also named Stephen, had the telltale swollen skin and absent eyebrows of a chemotherapy patient. The boy was in ...

 


BeiGene Presents Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) in Non-Hodgkin's Lymphoma ... - GlobeNewswire (press release)



BeiGene Presents Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) in Non-Hodgkin's Lymphoma ... 
GlobeNewswire (press release)
CAMBRIDGE, Mass. and BEIJING, China, Dec. 09, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the ...

and more » 


Roche lymphoma drug drives high remission rate, longer survival-study - Reuters



Roche lymphoma drug drives high remission rate, longer survival-study 
Reuters
Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone ...

and more » 


Clinical Data for eFFECTOR Therapeutics' Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated ... - Markets Insider



Clinical Data for eFFECTOR Therapeutics' Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated ... 
Markets Insider
Data presented on eFT508 by Ajay K. Gopal, M.D., of University of Washington and Fred Hutchinson Cancer Center, showed that, out of 10 patients treated and evaluable for drug efficacy, one patient with non-germinal center B-cell like diffuse large B ...

and more » 


Contamination near Marine Corps bases a common problem across ... - Island Packet



Island Packet
 
Contamination near Marine Corps bases a common problem across ... 
Island Packet
For decades, active duty Marines, their spouses, and their children have lived in houses and neighborhoods brimming with toxic chemicals, jet fuel, oil and pesticides that have long been banned. At the Laurel Bay Marine housing community near Beaufort ...

and more » 


Zanubrutinib Highly Active in Non-Hodgkin Lymphoma - OncLive - OncLive



OncLive
 
Zanubrutinib Highly Active in Non-Hodgkin Lymphoma - OncLive 
OncLive
The investigational BTK inhibitor zanubrutinib (BGB-3111) demonstrated promising clinical activity in patients with non-Hodgkin lymphoma (NHL), according to findings from a phase Ib study presented at the 2017 ASH Annual Meeting. Among patients with ...

and more » 


Last day to double your Season for Caring donation - Austin American-Statesman (blog)



Austin American-Statesman (blog)
 
Last day to double your Season for Caring donation 
Austin American-Statesman (blog)
Her daughter Samanta, 25, was diagnosed with non-Hodgkin's lymphoma in January. ? Hospice Austin, Marcelo Gracia: Marcelo Gracia, 45, was diagnosed with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, in 2011. His son Gael ...

and more »